10941/13381US=2 / Biol/Mol
Mehlen P, Lourenço FC. Death receptor: dependence receptors and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 157-82. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; RECEPTORES DE DEPENDENCIA; APOPTOSE; INTEGRINA; TIROSINA QUINASE

10942/13381US=2 / Biol/Mol
Saelens X, Festjens N, Walle LV, Vandenabeele P. Mitochondria: role of mitochondrial proteins in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 183-221. ISBN 978-3-527-31237-5.

APOPTOSE; PAPEL DAS PROTEINAS MITOCONDRIAIS; FAMILIA BCL-2; PERMEABILIZACAO DA MEMBRANA MITOCONDRIAL; MUTACOES APOPTOTICAS; CITOCROMO C

10943/13381US=2 / Biol/Mol
Suzuki Y, Takahashi R. Mitochondria: omi/HtrA2: a mitochondrial serine protease regulating cellular life and death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 222-32. ISBN 978-3-527-31237-5.

MITOCONDRIAS; OMI/HTRA2; SERINA PROTEASE MITOCONDRIAL; MORTE CELULAR

10944/13381US=2 / Biol/Mol
Vahsen N, Kroemer G. Mitochondria: apoptosis-inducing factor. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 233-55. ISBN 978-3-527-31237-5.

MITOCONDRIAS; FATOR DE INDUCAO DE APOPTOSE; ISOFORMES

10945/13381US=2 / Biol/Mol
Adrain C, Martin SJ. Effector systems: caspases: agents of defense and destruction. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 259-81. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; CASPASES; APOPTOSE

10946/13381US=2 / Biol/Mol
Cain K. Effector systems: the role of the apoptosome and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 282-313. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; TERAPIA APOPTOSSOMO; CANCER; CITOCROMO C; CASPASE

10947/13381US=2 / Biol/Mol
Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE

10948/13381US=2 / Biol/Mol
Dempsey CE, Roberts DL, Dive C. Bcl-2 family: bax, bak and bid: key mediators of apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 346-78. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; BAX; BAK; BID; MEDIADORES DE APOPTOSE; VIAS MITOCONDRIAIS; CANCER

10949/13381US=2 / Biol/Mol
Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR

10950/13381US=2 / Biol/Mol
Holcik M. IAPs: inhibitor of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 403-26. ISBN 978-3-527-31237-5.

IAPS; INIBIDORES DE PROTEINAS DE APOPTOSE

10951/13381US=2 / Biol/Mol
Altieri DC. IAPs: targeting the survivin pathway for rational cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 427-42. ISBN 978-3-527-31237-5.

IAPS; SURVIVINA; INIBIDOR DE PROTEINA A APOPTOSE

10952/13381US=2 / Biol/Mol
Greten FR, Karin M. Survival pathways: nuclear factor-kB in apoptosis and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 443-61. ISBN 978-3-527-31237-5.

CANCER; FATOR NUCLEAR-KB; APOPTOSE; CARCINOGENESE

10953/13381US=2 / Biol/Mol
Scheid MP, Woodgett JR. Survival pathways: cell survival through phosphoinositide 3-kinase and protein kinase B. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 463-89. ISBN 978-3-527-31237-5.

SOBREVIVENCIA CELULAR; FOSFATIDILINOSITOL 3-QUINASE; PROTEINA QUINASE B; MTOR

10954/13381US=2 / Biol/Mol
Drexler HCA, Hekman GM, Albert S, Rapp UR. Survival pathways: survival regulation by ras and raf. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 490-513. ISBN 978-3-527-31237-5.

CONTROLE DE SOBREVIVENCIA; RAS; RAF; APOPTOSE

10955/13381US=2 / Biol/Mol
Speidel D, Deppert W. Oncogenes/tumor suppressor genes: p53-mediated apoptosis: a multifaceted story. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 515-35. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES DE TUMOR; P53; APOPTOSE MEDIADA

10956/13381US=2 / Biol/Mol
Ramadan S, Sayan E, Oberst A, Chikh A, Pietroni V, Rufini A, Melino G, Bernassola F. Oncogenes/tumor suppressor genes: p73 affects cell fate and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 536-50. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES TUMORAIS; P73; TUMORIGENESE

10957/13381US=2 / Biol/Mol
Chau BN, Bergseid J, Wang JYJ. Oncogenes/tumor suppressor genes: RB and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 551-67. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES DE TUMORES; RB; CANCER; APOPTOSE

10958/13381US=2 / Biol/Mol
Orrenius S, Zhivotovsky B. Modulators: calcium signaling in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 569-95. ISBN 978-3-527-31237-5.

MODULADORES; SINALIZACAO DE CALCIO; APOPTOSE; MORTE CELULAR

10959/13381US=2 / Biol/Mol
Kirkegaard-Sorensen T, Fehrenbacher N, Gyrd-Hansen M, Jaattela M. Lysosomes and nonapoptotic pathways: lysosomes and nonapoptotic pathways. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 599-622. ISBN 978-3-527-31237-5.

LISOSSOMOS; VIAS NAO-APOPTOTICAS; HIDROLASES LISOSSOMAIS; ROTA ENDOCITICA; ROTA BIOSSINTETICA; ROTA AUTOFAGICA

10960/13381US=2 / Biol/Mol
Lauber K, Wesselborg S. Phagocytosis/clearance: the role of "Eat Me", "Don´t Eat Me" and "Find Me" signals for efficient removal of apoptotic cells. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 623-46. ISBN 978-3-527-31237-5.

FAGOCITOSE; REMOCAO DE CELULAS; APOPTOSE; RESPOSTA POS-FAGOCITOSE; REMOCAO DE CELULAS APOPTOTICAS; AUTOIMUNIDADE

Primeira | Anterior | Próxima | Última